Article Details

Adding Durvalumab and Olaparib to Chemo Improves PFS in Endometrial Cancer

Retrieved on: 2023-10-21 21:32:19

Tags for this article:

Click the tags to see associated articles and topics

Adding Durvalumab and Olaparib to Chemo Improves PFS in Endometrial Cancer. View article details on HISWAI: https://www.cancertherapyadvisor.com/home/news/conference-coverage/european-society-for-medical-oncology-esmo/esmo-2023/durvalumab-olaparib-chemo-improves-pfs-endometrial-cancer/

Excerpt

Disclosures: This research was supported by AstraZeneca. Some study authors declared affiliations with biotech, pharmaceutical, and/or device ...

Article found on: www.cancertherapyadvisor.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up